GUCA1C
Basic information
Region (hg38): 3:108907792-108953879
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GUCA1C gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 15 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 1 | 0 |
Variants in GUCA1C
This is a list of pathogenic ClinVar variants found in the GUCA1C region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-108908042-C-T | not specified | Uncertain significance (Sep 26, 2022) | ||
3-108908098-C-G | not specified | Uncertain significance (Nov 15, 2021) | ||
3-108908148-A-C | not specified | Uncertain significance (Dec 01, 2022) | ||
3-108908195-C-G | not specified | Uncertain significance (Feb 21, 2024) | ||
3-108908201-T-G | not specified | Uncertain significance (Mar 02, 2023) | ||
3-108916159-A-G | not specified | Uncertain significance (Mar 12, 2024) | ||
3-108920452-A-C | not specified | Uncertain significance (Jan 03, 2024) | ||
3-108920461-T-C | not specified | Uncertain significance (Jul 25, 2023) | ||
3-108920518-T-A | not specified | Uncertain significance (Feb 28, 2023) | ||
3-108920518-T-C | not specified | Uncertain significance (Jul 19, 2022) | ||
3-108920528-T-G | not specified | Uncertain significance (Jul 19, 2023) | ||
3-108920536-A-C | not specified | Uncertain significance (May 04, 2022) | ||
3-108920575-A-G | not specified | Uncertain significance (Aug 28, 2021) | ||
3-108953566-G-A | not specified | Likely benign (Dec 21, 2021) | ||
3-108953720-G-T | not specified | Uncertain significance (Jun 30, 2023) | ||
3-108953726-C-T | not specified | Uncertain significance (Dec 09, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GUCA1C | protein_coding | protein_coding | ENST00000261047 | 4 | 46104 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.57e-7 | 0.0907 | 62931 | 11564 | 51215 | 125710 | 0.292 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.317 | 116 | 107 | 1.09 | 0.00000484 | 1413 |
Missense in Polyphen | 24 | 22.199 | 1.0811 | 324 | ||
Synonymous | 0.763 | 33 | 39.1 | 0.845 | 0.00000189 | 361 |
Loss of Function | -0.669 | 9 | 7.08 | 1.27 | 3.00e-7 | 84 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.607 | 0.606 |
Ashkenazi Jewish | 0.223 | 0.221 |
East Asian | 0.157 | 0.157 |
Finnish | 0.330 | 0.329 |
European (Non-Finnish) | 0.325 | 0.323 |
Middle Eastern | 0.157 | 0.157 |
South Asian | 0.240 | 0.236 |
Other | 0.298 | 0.299 |
dbNSFP
Source:
- Function
- FUNCTION: Stimulates guanylyl cyclase 1 (GC1) and GC2 when free calcium ions concentration is low and inhibits guanylyl cyclases when free calcium ions concentration is elevated. This Ca(2+)- sensitive regulation of guanylyl cyclase (GC) is a key event in recovery of the dark state of rod photoreceptors following light exposure.;
- Pathway
- Phototransduction - Homo sapiens (human);Signaling by GPCR;Signal Transduction;Visual signal transduction: Rods;G alpha (i) signalling events;Inactivation, recovery and regulation of the phototransduction cascade;The phototransduction cascade;Visual phototransduction;GPCR downstream signalling;Visual signal transduction: Cones
(Consensus)
Recessive Scores
- pRec
- 0.104
Intolerance Scores
- loftool
- 0.698
- rvis_EVS
- 0.99
- rvis_percentile_EVS
- 90.56
Haploinsufficiency Scores
- pHI
- 0.0467
- hipred
- N
- hipred_score
- 0.187
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0242
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | High | Medium | High |
Gene ontology
- Biological process
- signal transduction;visual perception;regulation of rhodopsin mediated signaling pathway;positive regulation of guanylate cyclase activity
- Cellular component
- photoreceptor disc membrane
- Molecular function
- calcium ion binding;calcium sensitive guanylate cyclase activator activity